GlassScriptPhysician profile
William D Thompson
NPI 1619916970
$2,970.38
in general payments reported to CMS, 2019-2025
17 companies · $461 in 2025
The $461 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $467 · 2020: $190 · 2021: $56.57 · 2022: $539 · 2023: $720 · 2024: $536 · 2025: $461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,717.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,066.46 | 2019-2025 | Watchman Access System, Watchman Flx |
| Abbott Laboratories | $786.30 | 2020-2025 | Ensite Precision |
| Biosense Webster, INC. | $479.89 | 2019-2024 | Carto 3, Nuvision Ice Catheter, Soundstar |
| Medtronic, INC. | $195.45 | 2025 | Micra, Plasmablade(Tm) |
| Philips North America LLC | $108.23 | 2024 | (9148) Ice 3d |
| Janssen Pharmaceuticals, INC | $55.43 | 2019-2022 | |
| Atricure, INC. | $43.71 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Inspire Medical Systems, INC. | $42.23 | 2023 | Inspire |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $32.79 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $32.38 | 2022-2024 | Eliquis |
| Sanofi-Aventis U.S. LLC | $27.80 | 2023-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.93 | 2023 | Jardiance |
| Medtronic Vascular, INC. | $16.87 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $16.25 | 2024 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $15.35 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $13.39 | 2023 | Repatha |
| Elutia, INC. | $11.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.